News
Press Release
Axplora invests €8 million in Le Mans to further expand its capacity for antibody drug conjugate manufacturing
Axplora strengthens its innovative position in oncology to enable cancer care for patients: €8M investment on its Le Mans (Fr) site, with the support of the France 2030 program, to expand its production capabilities for the manufacturing of ADCs, offering high-quality services for our customers and cutting-edge drugs for millions of patients worldwide. Read the full press release to know more!
News
CPHI worldwide 2023 continuity: Interview with Arul Ramadurai, CCO
News
CPHI 2023: Interview with Dr. Sylke Hassel, CEO
Press Release
Axplora announces the appointment of its Scientific Advisory Board
News
Axplora’s Ursodeoxycholic Receives 5-Year Renewed Registration
Press Release